[Gardasil®-induced erythema nodosum]

C Longueville; V Doffoel-Hantz; S Hantz; N Souyri; Y Nouaille; C Bédane; A Sparsa

doi:10.1016/j.revmed.2011.02.013

[Gardasil®-induced erythema nodosum]

Rev Med Interne. 2012 Mar;33(3):e17-8. doi: 10.1016/j.revmed.2011.02.013. Epub 2011 Mar 23.

[Article in French]

Authors

C Longueville¹, V Doffoel-Hantz, S Hantz, N Souyri, Y Nouaille, C Bédane, A Sparsa

Affiliation

¹ Service de dermatologie, CHU Dupuytren, 2 avenue Martin-Luther-King, Limoges, France.

PMID: 21435755
DOI: 10.1016/j.revmed.2011.02.013

Abstract

Erythema nodosum is a panniculitis occurring more frequently in young women. We report a 16-year-old woman who presented with erythema nodosum that occurred following Gardasil® administration (vaccine against HPV types 6, 11, 16 and 18) and that is proposed to young female. This adverse effect is not a contraindication to the HPV vaccination because its benefit against the oncogene risk of Papillomavirus is documented.

Publication types

Case Reports
English Abstract

MeSH terms

Adolescent
Erythema Nodosum / chemically induced*
Erythema Nodosum / diagnosis
Female
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
Humans
Papillomavirus Vaccines / adverse effects*

Substances

Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
Papillomavirus Vaccines